And with no admitted fault or failure, I'm delighted that we've also drawn a line under the vast majority of Zantac litigation ... our antibody drug conjugate for extensive stage small-cell ...

“But GSK is showing strength elsewhere in its portfolio with 19% growth ... settlement to resolve tens of thousands of ...

Sanofi's existing product line boasts several top-tier drugs, including immunology drug Dupixent ... related to the increasingly concerning Zantac litagation. Overall, we rate Sanofi’s ...

“But GSK is showing strength elsewhere in its portfolio with ... of lawsuits in the US over its discontinued heartburn drug Zantac earlier in October.

So why would GSK, the largest of the four major distributors of the now-recalled stomach acid drug, suddenly abandon the tried-and-true defense mantra, “millions for defense, not a penny for tribute”?

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.